Perfil
Chris Bunge is currently a Senior Analyst at Opaleye Management, Inc. since 2023.
Formerly, Mr. Bunge was a Portfolio Manager at WaterMill Asset Management from 2017 to 2024 and an Analyst at Manalapan Oracle Advisers LLC from 2013 to 2014.
Mr. Bunge completed an undergraduate degree at Bentley University in 2013.
Cargos activos de Chris Bunge
| Empresas | Cargo | Inicio |
|---|---|---|
Opaleye Management, Inc.
Opaleye Management, Inc. Investment ManagersFinance Opaleye employs a research process that involves analyzing company fundamentals, such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition. The firm’s strategy for managing the Fund is to actively invest, both long and short, in equity securities of US and foreign small and mid-cap biotechnology, specialty pharmaceutical and med-device companies. | Analyst-Equity | 01/11/2023 |
Antiguos cargos conocidos de Chris Bunge.
| Empresas | Cargo | Fin |
|---|---|---|
WaterMill Asset Management
WaterMill Asset Management Investment ManagersFinance WaterMill Asset Management invests in both private and public companies. | Gestor de Cartera-Acciones | 01/01/2024 |
Manalapan Oracle Advisers LLC
Manalapan Oracle Advisers LLC Investment ManagersFinance Profile Unavailable. | Analyst-Equity | 01/04/2014 |
Formación de Chris Bunge.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opaleye Management, Inc.
Opaleye Management, Inc. Investment ManagersFinance Opaleye employs a research process that involves analyzing company fundamentals, such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition. The firm’s strategy for managing the Fund is to actively invest, both long and short, in equity securities of US and foreign small and mid-cap biotechnology, specialty pharmaceutical and med-device companies. | Finance |
Manalapan Oracle Advisers LLC
Manalapan Oracle Advisers LLC Investment ManagersFinance Profile Unavailable. | Finance |
WaterMill Asset Management
WaterMill Asset Management Investment ManagersFinance WaterMill Asset Management invests in both private and public companies. | Finance |
- Bolsa de valores
- Insiders
- Chris Bunge
















